Precigen director receives stock, RSU and option grants

PRECIGEN, INC. director Cesar L. Alvarez received equity-based compensation rather than cash.

Rhea-AI Filing Summary

PRECIGEN, INC. director Cesar L. Alvarez received equity-based compensation rather than cash. He was issued 17,806 shares of common stock at $3.51 per share in lieu of an annual retainer of $62,500.

Alvarez was also granted 35,612 restricted stock units, each representing one share of common stock, which vest in full on March 10, 2027. In addition, he received an option to purchase 41,073 shares of common stock at an exercise price of $3.51 per share, expiring on March 10, 2036. Following these awards, he directly owns 711,070 common shares. These are compensation grants, not open-market purchases.

Insider Trade Summary

Grant/Award: 94,491 shares

Grant/Award 3 txns

Insider ALVAREZ CESAR L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	35,612	$0.00	$0.00
Grant/Award	Option to Purchase Common Stock (Right to Buy)	41,073	$0.00	$0.00
Grant/Award	Common Stock	17,806	$3.51	$62K

Holdings After Transaction: Restricted Stock Units — 35,612 contracts (Direct); Option to Purchase Common Stock (Right to Buy) — 41,073 contracts (Direct); Common Stock — 711,070 shares (Direct)

Footnotes (3)

1. F1. The shares were issued to the reporting person in lieu of an annual retainer of $62,500.
2. F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
3. F3. The RSUs vest in full on March 10, 2027.

FAQ

What did PRECIGEN (PGEN) director Cesar Alvarez receive in this Form 4 filing?

Cesar Alvarez received equity-based compensation, including common stock, restricted stock units, and stock options. These awards compensate him for board service and replace a portion of cash fees with company equity, aligning his interests more closely with other shareholders over time.

How many PRECIGEN (PGEN) common shares were issued to Cesar Alvarez as fees?

Cesar Alvarez was issued 17,806 shares of PRECIGEN common stock. The footnotes state these shares were granted in lieu of an annual cash retainer of $62,500, effectively paying his board fee with stock rather than cash at a price of $3.51 per share.

What are the terms of the restricted stock units granted to Cesar Alvarez at PRECIGEN (PGEN)?

Cesar Alvarez was granted 35,612 restricted stock units, each representing one share of PRECIGEN common stock. The RSUs vest in full on March 10, 2027, meaning he must remain eligible through that date to receive the underlying shares without restrictions.

What stock option grant did Cesar Alvarez receive from PRECIGEN (PGEN)?

He received an option to purchase 41,073 shares of PRECIGEN common stock. The option has an exercise price of $3.51 per share and an expiration date of March 10, 2036, giving him a long-dated right to buy shares at that price if conditions are met.

How many PRECIGEN (PGEN) shares does Cesar Alvarez hold after these transactions?

After the reported transactions, Cesar Alvarez directly owns 711,070 shares of PRECIGEN common stock. This figure reflects his updated equity position following the grant of compensation shares in lieu of cash and does not include the unexercised stock options reported separately.

Are the PRECIGEN (PGEN) equity awards to Cesar Alvarez open-market purchases or compensation?

The awards are compensation grants, not open-market purchases. Footnotes explain that the common shares were issued instead of a $62,500 cash retainer, and the restricted stock units and options are standard equity compensation tied to his role as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALVAREZ CESAR L

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		17,806	A	$3.51(1)	711,070	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/10/2026		A		35,612		(3)	(3)	Common Stock	35,612	$0	35,612	D
Option to Purchase Common Stock (Right to Buy)	$3.51	03/10/2026		A		41,073		03/10/2026	03/10/2036	Common Stock	41,073	$0	41,073	D

Explanation of Responses:

1. The shares were issued to the reporting person in lieu of an annual retainer of $62,500.

2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

3. The RSUs vest in full on March 10, 2027.

	/s/ Cesar L. Alvarez, by Donald P. Lehr, as attorney-in-fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.